foxo4 dri senolytic human trial 2024 2025 Molecular modelling of the FOXO4-TP53 interaction to design peptides for the elimination of senescent cancer cells State Department Agents Are Variant:20mg red blood cell support
Pay in 4 interest-free payments of $6.21 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 21 - Oct 26